Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2025 Aug 4;15(1):28358.
doi: 10.1038/s41598-025-09783-5.

Curcumin supplementation improves the clinical outcomes of patients with diabetes and atherosclerotic cardiovascular risk

Affiliations
Randomized Controlled Trial

Curcumin supplementation improves the clinical outcomes of patients with diabetes and atherosclerotic cardiovascular risk

Omar M El-Rakabawy et al. Sci Rep. .

Abstract

Atherosclerotic cardiovascular diseases (ASCVD) significantly contribute to global mortality, especially in type 2 diabetes mellitus (T2DM), necessitating effective preventive strategies. Curcumin is proposed to lower blood pressure, glucose level, and improve lipid profiles as an adjunctive treatment. The study aimed to assess the safety and efficacy of Curcumin supplementation on clinical outcomes and ASCVD risk of T2DM patients. Seventy-two diabetic patients with an ASCVD risk score of ≥ 5% were randomly assigned to Curcumin group (500 mg Turmeric curcumin® thrice daily + conventional therapy) or Control group (conventional therapy only). Curcumin significantly reduced SBP and DBP (P ≤ 0.001 and P = 0.020, respectively) and improved ASCVD risk classification (P = 0.004). LDL-C (P = 0.024), TNF-α (P = 0.044), and MDA (P = 0.028) levels decreased, while HDL-C increased (P = 0.024) versus control. No significant differences were found between groups regarding HbA1c, FBG, TC or TG (P > 0.05). Mild adverse effects were reported, including nausea (13.9%), headache (11.1%), yellow stool (11.1%), and diarrhea (5.6%). It is concluded that Curcumin improves ASCVD risk classification, lowers SBP, DBP, LDL-C, TNF-alpha, and MDA, increases HDL-C, and is well tolerated with minor adverse effects, without impacting on BMI, HR, HbA1c, FBG, TC, or TG.

Keywords: ASCVD; Curcumin; Diabetes mellitus; Hypertension; MDA; TNF-alpha.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
CONSORT Flow Diagram.
Fig. 2
Fig. 2
Change in Blood pressure between Curcumin and Control groups at baseline and over time. (a) Systolic blood pressure (SBP); (b) Diastolic blood pressure (DBP).
Fig. 3
Fig. 3
Change in ASCVD risk classes between Curcumin and Control groups at baseline (a) and at the end of the study (b).
Fig. 4
Fig. 4
Change in Laboratory Parameters between Curcumin and Control groups at baseline and over time. (a) Malondialdehyde; (b) TNF-alpha; (c) Total cholesterol; (d) LDL-cholesterol; (e) HDL-cholesterol.

References

    1. Punthakee, Z., Goldenberg, R., Katz, P. & Definition Classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Can. J. Diabetes. 42, S10–S15 (2018). - PubMed
    1. Ramachandran, A. Know the signs and symptoms of diabetes. Vol. 140, Indian Journal of Medical Research. Medknow; pp. 579–81 (2014). - PMC - PubMed
    1. Antar, S. A. et al. Diabetes mellitus: classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments. Biomed. Pharmacother. 168, 115734 (2023). - PubMed
    1. Deshpande, A. D., Harris-Hayes, M. & Schootman, M. Epidemiology of diabetes and diabetes-related complications. Phys. Ther.88 (11), 1254–1264 (2008). - PMC - PubMed
    1. Zibaeenejad, F., Mohammadi, S. S., Sayadi, M., Safari, F. & Zibaeenezhad, M. J. Ten-year atherosclerosis cardiovascular disease (ASCVD) risk score and its components among an Iranian population: a cohort-based cross-sectional study. BMC Cardiovasc. Disord.22(1), 162 (2022). - PMC - PubMed

Publication types